Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-19

FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Alvogen, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for levothyroxine sodium submitted by Alvogen, Inc., indicating an approved change to an existing product. The actio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

SUPPL AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)